Forbion Capital Fund III Cooperatief U.A. 13D/13G Filings for Milestone Pharmaceuticals Inc. (MIST)

Forbion Capital Fund III Cooperatief U.A. 13D and 13G filings for Milestone Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
06:10 am
Sale
2020-12-3113GMilestone Pharmaceuticals Inc.
MIST
Forbion Capital Fund III Cooperatief U.A.0
0.000%
-1,303,902decrease
(Position Closed)
Filing